Error: No layouts found
From left, Jonathan Segal; Danielle Cohen Segal, EEL executive chair; Teresa V. Bowman, Ph.D.; Ruth L. Gottesman, Ed.D., chair emerita, Einstein Board of Overseers; and Dean Allen M. Spiegel, M.D.
Top Banner: From left, Tommy Shaffer and Danielle Lotardo with EEL executive board members Amanda and Joseph Sipala.
Members and friends of Einstein Emerging Leaders (EEL) came out for “Cocktails & Conversation,” an evening of meeting, mingling and hearing about some of the current research being conducted at the Albert Einstein Cancer Center, on May 12, at the Norwood Club in Manhattan. The event benefited cancer research at Einstein.
Danielle Cohen Segal, EEL’s executive chair, welcomed the attendees. “As you may have heard,” she said, “Einstein is in the process of deepening its ties with Montefiore Health System. For those of us in EEL, this newly expanded, dynamic relationship will provide additional ways to get involved.”
Ms. Segal then introduced Teresa V. Bowman, Ph.D., the featured guest speaker. Dr. Bowman is an assistant professor of developmental and molecular biology and of medicine (oncology) at Einstein. She discussed her research on hematopoietic stem cell regeneration and the molecular origins of myelodysplastic syndromes (MDS), incurable diseases that can result in leukemia. Dr. Bowman’s work may lead to new targeted therapies for MDS and leukemia.
EEL executive board members Matt Makovsky, Amanda and Joseph Sipala, Joanna Steinberg and David Weinreb served as the host committee for
the event.
Einstein Emerging Leaders are philanthropic New York City professionals committed to advancing Einstein’s mission to improve human health. EEL hosts a variety of educational programs, volunteer activities and fundraising events throughout the year. To learn more, please contact Eve Marsan at eve.marsan@einstein.yu.edu.
